There are a variety of therapies available compared to early in the pandemic. It's hard to imagine a time when treatments weren't available for COVID-19. Yet this was the case when the World Health ...

The treatments were highly popular earlier in the pandemic. One by one, they got knocked out by more convenient, less expensive treatment options,... How monoclonal antibodies lost the fight with new ...

Starting next year, an anti-viral drug for fighting COVID-19, Paxlovid, will no longer be paid for by the federal government, shifting costs to private insurance for those who have it. Paxlovid is ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19. The four drugs -- bebtelovimab, sotrovimab, casirivimab ...

4/21/25 (LAPost.com) — Most approved COVID-19 treatments cause few serious side effects, according to new research from the Keck School of Medicine of the University of Southern California. The ...